| Item Type | Name |
|
Academic Article
|
HBsAg seropositive status and survival after renal transplantation: meta-analysis of observational studies.
|
|
Academic Article
|
Predictors of treatment in patients with chronic hepatitis C infection - role of patient versus nonpatient factors.
|
|
Academic Article
|
Viral RNA testing in hepatitis C antibody-positive veterans.
|
|
Academic Article
|
Impact of hepatitis C on health related quality of life: a systematic review and quantitative assessment.
|
|
Academic Article
|
Treatment alternatives for chronic hepatitis B virus infection: a cost-effectiveness analysis.
|
|
Academic Article
|
Quality of care in patients with chronic hepatitis C virus infection: a cohort study.
|
|
Academic Article
|
Importance of patient, provider, and facility predictors of hepatitis C virus treatment in veterans: a national study.
|
|
Academic Article
|
Utilization of surveillance for hepatocellular carcinoma among hepatitis C virus-infected veterans in the United States.
|
|
Academic Article
|
Screening high risk individuals for hepatitis B: physician knowledge, attitudes, and beliefs.
|
|
Academic Article
|
The performance of process measures in hepatitis C.
|
|
Academic Article
|
Process of care for hepatitis C infection is linked to treatment outcome and virologic response.
|
|
Academic Article
|
a-Fetoprotein in hepatocellular carcinoma surveillance: mend it but do not end it.
|
|
Academic Article
|
The association between serological and dietary vitamin D levels and hepatitis C-related liver disease risk differs in African American and white males.
|
|
Academic Article
|
Development and validation of a disease-targeted quality of life instrument in chronic hepatitis B: the hepatitis B quality of life instrument, version 1.0.
|
|
Academic Article
|
Hepatitis vaccination in patients with hepatitis C: practice and validation of codes at a large Veterans Administration Medical Centre.
|
|
Academic Article
|
Lack of association between hepatitis C infection and chronic kidney disease.
|
|
Academic Article
|
Transforming strategies for the prevention of chronic HBV and HCV infections.
|
|
Academic Article
|
Meeting vaccination quality measures for hepatitis A and B virus in patients with chronic hepatitis C infection.
|
|
Academic Article
|
National patterns and predictors of liver biopsy use for management of hepatitis C.
|
|
Academic Article
|
Referral and receipt of treatment for hepatocellular carcinoma in United States veterans: effect of patient and nonpatient factors.
|
|
Academic Article
|
Boceprevir and telaprevir in the management of hepatitis C virus-infected patients.
|
|
Academic Article
|
CDC and USPSTF 2012 recommendations for screening for hepatitis C virus infection: overview and take-home messages.
|
|
Academic Article
|
Impact of chronic viral hepatitis on health-related quality of life in HIV: results from a nationally representative sample.
|
|
Academic Article
|
Post-transplant diabetes mellitus and HCV seropositive status after renal transplantation: meta-analysis of clinical studies.
|
|
Academic Article
|
Treatment alternatives for hepatitis B cirrhosis: a cost-effectiveness analysis.
|
|
Academic Article
|
Increasing prevalence of HCC and cirrhosis in patients with chronic hepatitis C virus infection.
|
|
Academic Article
|
Insurance status and treatment candidacy of hepatitis C patients: analysis of population-based data from the United States.
|
|
Academic Article
|
CDC and USPSTF 2012 recommendations for screening for hepatitis C virus infection: overview and take-home messages.
|
|
Concept
|
Hepatitis B Surface Antigens
|
|
Concept
|
Hepatitis, Alcoholic
|
|
Concept
|
Hepatitis B virus
|
|
Concept
|
Viral Hepatitis Vaccines
|
|
Concept
|
Hepatitis C Antibodies
|
|
Concept
|
Hepatitis, Autoimmune
|
|
Concept
|
Hepatitis B
|
|
Concept
|
Hepatitis, Viral, Human
|
|
Concept
|
Hepatitis C
|
|
Concept
|
Hepatitis C, Chronic
|
|
Concept
|
Hepatitis A Vaccines
|
|
Concept
|
Hepatitis B Antibodies
|
|
Concept
|
Hepatitis B e Antigens
|
|
Concept
|
Hepatitis B, Chronic
|
|
Concept
|
Hepatitis A Antibodies
|
|
Concept
|
Hepatitis B Vaccines
|
|
Academic Article
|
Hepatocellular carcinoma screening practices in the Department of Veterans Affairs: findings from a national facility survey.
|
|
Academic Article
|
Association between facility characteristics and the process of care delivered to patients with hepatitis C virus infection.
|
|
Academic Article
|
Many patients with interleukin 28B genotypes associated with response to therapy are ineligible for treatment because of comorbidities.
|
|
Academic Article
|
The impact of hepatitis C burden: an evidence-based approach.
|
|
Academic Article
|
A new laboratory-based algorithm to predict development of hepatocellular carcinoma in patients with hepatitis C and cirrhosis.
|
|
Academic Article
|
The end of hepatitis C.
|
|
Academic Article
|
HCV genotype 3 is associated with an increased risk of cirrhosis and hepatocellular cancer in a national sample of U.S. Veterans with HCV.
|
|
Academic Article
|
Hepatitis C virus infection and coronary artery disease risk: a systematic review of the literature.
|
|
Academic Article
|
Hepatitis C virus treatment: the unyielding chasm between efficacy and effectiveness.
|
|
Academic Article
|
Racial differences in the progression to cirrhosis and hepatocellular carcinoma in HCV-infected veterans.
|
|
Academic Article
|
Clinical outcomes of hepatitis B virus coinfection in a United States cohort of hepatitis C virus-infected patients.
|
|
Academic Article
|
Sex hormone pathway gene polymorphisms are associated with risk of advanced hepatitis C-related liver disease in males.
|
|
Academic Article
|
Cost-effectiveness and budget impact of hepatitis C virus treatment with sofosbuvir and ledipasvir in the United States.
|
|
Academic Article
|
Genetic Variants in Interleukin-28B Are Associated with Diabetes and Diabetes-Related Complications in Patients with Chronic Hepatitis C Virus Infection.
|
|
Academic Article
|
Coffee and Caffeine Are Associated With Decreased Risk of Advanced Hepatic Fibrosis Among Patients With Hepatitis C.
|
|
Academic Article
|
Why We Should Be Willing to Pay for Hepatitis C Treatment.
|
|
Academic Article
|
Pay for Performance in Chronic Liver Disease.
|
|
Academic Article
|
Qualitative analysis of patient-centered decision attributes associated with initiating hepatitis C treatment.
|
|
Academic Article
|
The Updated Model: An Adjusted Serum Alpha-Fetoprotein-Based Algorithm for Hepatocellular Carcinoma Detection With Hepatitis C Virus-Related Cirrhosis.
|
|
Academic Article
|
Risk of hepatocellular carcinoma after sustained virological response in Veterans with hepatitis C virus infection.
|
|
Academic Article
|
Epidemiology and outcomes of hepatitis C infection in elderly US Veterans.
|
|
Academic Article
|
Race and Gender Differences in the Use of Direct Acting Antiviral Agents for Hepatitis C Virus.
|
|
Academic Article
|
Collaborative Care for Depression in Chronic Hepatitis C Clinics.
|
|
Academic Article
|
Hepatocellular carcinoma in the absence of cirrhosis in patients with chronic hepatitis B virus infection.
|
|
Academic Article
|
Role of Non-hepatic Medical Comorbidity and Functional Limitations in Predicting Mortality in Patients with HCV.
|
|
Academic Article
|
Optimal timing of hepatitis C treatment for patients on the liver transplant waiting list.
|
|
Academic Article
|
Global epidemiology and burden of HCV infection and HCV-related disease.
|
|
Academic Article
|
Incidence and Determinants of Hepatocellular Carcinoma in Autoimmune Hepatitis: A Systematic Review and Meta-analysis.
|
|
Academic Article
|
Hepatitis C Disease Burden in the United States in the era of oral direct-acting antivirals.
|
|
Academic Article
|
The Validity of HCC Diagnosis Codes in Chronic Hepatitis B Patients in the Veterans Health Administration.
|
|
Academic Article
|
Cost Effectiveness of Pre- vs Post-Liver Transplant Hepatitis C Treatment With Direct-Acting Antivirals.
|
|
Academic Article
|
Reply to: "Hepatocellular carcinoma (HCC) in the absence of cirrhosis in patients with chronic hepatitis B virus infection".
|
|
Academic Article
|
Risk of Hepatocellular Cancer in HCV Patients Treated With Direct-Acting Antiviral Agents.
|
|
Academic Article
|
Hepatitis C and Risk of Nonhepatic Malignancies.
|
|
Academic Article
|
Hepatitis C virus-related complications are increasing in women veterans: A national cohort study.
|
|
Academic Article
|
Hepatitis C Virus Infection Care Pathway-A Report From the American Gastroenterological Association Institute HCV Care Pathway Work Group.
|
|
Academic Article
|
Barriers to hepatitis C treatment in the era of direct-acting anti-viral agents.
|
|
Academic Article
|
Hepatitis C virus re-treatment in the era of direct-acting antivirals: projections in the USA.
|
|
Academic Article
|
A Randomized Trial of Off-Site Collaborative Care for Depression in Chronic Hepatitis C Virus.
|
|
Academic Article
|
Transplanting hepatitis C virus-positive livers into hepatitis C virus-negative patients with preemptive antiviral treatment: A modeling study.
|
|
Academic Article
|
Evaluating screening approaches for hepatocellular carcinoma in a cohort of HCV related cirrhosis patients from the Veteran's Affairs Health Care System.
|
|
Academic Article
|
Role of Age and Race in the Risk of Hepatocellular Carcinoma in Veterans With Hepatitis B Virus Infection.
|
|
Academic Article
|
Real-world effectiveness of elbasvir/grazoprevir In HCV-infected patients in the US veterans affairs healthcare system.
|
|
Academic Article
|
Cost Effectiveness of Transplanting HCV-Infected Livers Into Uninfected Recipients With Preemptive Antiviral Therapy.
|
|
Academic Article
|
Validation of the Hepatocellular Carcinoma Early Detection Screening (HES) Algorithm in a Cohort of Veterans With Cirrhosis.
|
|
Academic Article
|
Awareness of chronic viral hepatitis in the United States: An update from the National Health and Nutrition Examination Survey.
|
|
Grant
|
Care for Women Veterans with Hepatitis C Virus Infection
|
|
Academic Article
|
AGA Clinical Practice Update on Interaction Between Oral Direct-Acting Antivirals for Chronic Hepatitis C Infection and Hepatocellular Carcinoma: Expert Review.
|
|
Academic Article
|
The effects of sustained virological response to direct-acting anti-viral therapy on the risk of extrahepatic manifestations of hepatitis C infection.
|
|
Academic Article
|
Surveillance for Hepatocellular Carcinoma: Current Best Practice and Future Direction.
|
|
Academic Article
|
Risk of Hepatocellular Cancer Recurrence in Hepatitis C Virus+ Patients Treated with Direct-Acting Antiviral Agents.
|
|
Academic Article
|
Assessment of the Feasibility and Cost of Hepatitis C Elimination in Pakistan.
|
|
Academic Article
|
The impact of direct-acting anti-virals on the hepatitis C care cascade: identifying progress and gaps towards hepatitis C elimination in the United States.
|
|
Academic Article
|
Changes in hepatitis C burden and treatment trends in Europe during the era of direct-acting antivirals: a modelling study.
|
|
Academic Article
|
Long-Term Risk of Hepatocellular Carcinoma in HCV Patients Treated With Direct Acting Antiviral Agents.
|
|
Academic Article
|
The HCV Treatment Cascade: Race Is a Factor to Consider.
|
|
Academic Article
|
Effectiveness of Elbasvir/Grazoprevir in patients with hepatitis C virus genotype 1 infection and chronic kidney disease in the United States veterans population.
|
|
Academic Article
|
Risk Factors for Cirrhosis in Contemporary Hepatology Practices-Findings From the Texas Hepatocellular Carcinoma Consortium Cohort.
|
|
Academic Article
|
Effectiveness of Elbasvir/Grazoprevir in US Veterans with Chronic Hepatitis C Virus Genotype 1b Infection.
|
|
Academic Article
|
AGA Clinical Practice Update on Interaction Between Oral Direct-Acting Antivirals for Chronic Hepatitis C Infection and Hepatocellular Carcinoma: Expert Review.
|
|
Academic Article
|
Clinical efficacy of direct-acting antiviral therapy for recurrent hepatitis C virus infection after liver transplantation in patients with hepatocellular carcinoma.
|
|
Academic Article
|
Assessment of Incidence of and Surveillance Burden for Hepatocellular Carcinoma Among Patients With Hepatitis C in the Era of Direct-Acting Antiviral Agents.
|
|
Academic Article
|
Outcomes in the Era of Interferon-Free Direct-Acting Antiviral Therapy After Liver Transplantation in Patients with Hepatitis C Virus and Hepatocellular Carcinoma.
|
|
Academic Article
|
Impact of COVID-19 Pandemic on Liver Transplantation and Alcohol-Associated Liver Disease in the USA.
|
|
Academic Article
|
Comparative performance of risk prediction models for hepatitis B-related hepatocellular carcinoma in the United States.
|
|
Academic Article
|
Risk factors for HCC in contemporary cohorts of patients with cirrhosis.
|
|
Academic Article
|
The Risk of Hepatocellular Carcinoma in Entecavir Versus Tenofovir Treated US Cohort With Chronic Hepatitis B Virus.
|
|
Academic Article
|
Comparable Survival for Hepatitis C-Related Hepatocellular Carcinoma After Liver Transplantation Irrespective of Viremic Status.
|
|
Academic Article
|
Treatment of hepatitis C virus infection in people with opioid use disorder: a real-world study of elbasvir/grazoprevir in a US Department of Veterans Affairs population.
|
|
Academic Article
|
Duration and cost-effectiveness of hepatocellular carcinoma surveillance in hepatitis C patients after viral eradication.
|
|
Academic Article
|
Effectiveness of elbasvir/grazoprevir plus ribavirin for hepatitis C virus genotype 1a infection and baseline NS5A resistance.
|
|
Academic Article
|
Reduction in Racial and Ethnic Disparity in Survival Following Liver Transplant for Hepatocellular Carcinoma in the Direct-acting Antiviral Era.
|
|
Academic Article
|
Telehealth interventions in patients with chronic liver diseases: A systematic review.
|
|
Academic Article
|
Improved Survival After Liver Transplantation for Patients With Human Immunodeficiency Virus (HIV) and HIV/Hepatitis C Virus Coinfection in the Integrase Strand Transfer Inhibitor and Direct-Acting Antiviral Eras.
|
|
Academic Article
|
Longitudinal Associations of Risk Factors and Hepatocellular Carcinoma in Patients With Cured Hepatitis C Virus Infection.
|
|
Academic Article
|
Transplanting hepatitis B surface antigen-positive livers in the United States: Outcomes and opportunities.
|
|
Academic Article
|
Hepatocellular Carcinoma Incidence Threshold for Surveillance in Virologically Cured Hepatitis C Individuals.
|
|
Academic Article
|
Bioimpedance analysis predicts the etiology of cirrhosis in a prospective cohort study.
|
|
Academic Article
|
Global trends in hepatocellular carcinoma epidemiology: implications for screening, prevention and therapy.
|